SCHEMBL707060

SCHEMBL707060

O=S(=O)(O)C(C(F)c1ccccc1)S(=O)(=O)OCCOS(=O)(=O)C(C(F)c1ccccc1)S(=O)(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.43
ALDH1A1 P00352 2/20 0.39
CYP2C19 P33261 1/20 0.34
NPSR1 Q6W5P4 2/20 0.33
ACP1 P24666 2/20 0.33
PTPN12 Q05209 2/20 0.33
PTPN13 Q12923 2/20 0.33
SSU72 Q9NP77 2/20 0.33
CYP2D6 P10635 2/20 0.33
CYP1A2 P05177 1/20 0.33
PKM P14618 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PTPN7 P35236 1/20 0.33
MAPT P10636 2/20 0.32
PTPN1 P18031 2/20 0.32
PTPN6 P29350 2/20 0.32
PTPN11 Q06124 2/20 0.32
LMNA P02545 2/20 0.32
PMP22 Q01453 2/20 0.32
KMT2A Q03164 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene SCHEMBL707063 0.79 SRC (0.52) SRCALDH1A1CYP2C19NPSR1ACP1
SCHEMBL669211 0.67 SRC (0.54) SRCALDH1A1CYP2C19NPSR1ACP1
SCHEMBL28031021 0.67 SRC (0.59) SRCALDH1A1CYP2C19NPSR1ACP1
SCHEMBL4131267 0.66 SRC (0.40) SRCALDH1A1CYP2C19NPSR1CYP2D6
SCHEMBL10231832 0.65 NPSR1 (0.52) SRCALDH1A1CYP2C19NPSR1CYP2D6
SCHEMBL708123 0.64
Butane SCHEMBL9860417 0.63 SRC (0.46) SRCALDH1A1CYP2C19NPSR1CYP2D6
SCHEMBL7453634 0.63 SRC (0.52) SRCCYP2C19CYP2D6CYP1A2LMNA
SCHEMBL6491098 0.63 SRC (0.52) SRCCYP2C19CYP2D6CYP1A2LMNA
SCHEMBL915178 0.62 DPP4 (0.47) SRCCYP2D6LMNATSHRSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124793-B2 Derivatives of ethylene methanedisulfonate as cancer chemotherapeutic agents CRONYN MARSHALL W (US) 2012-02-28 US disclosed
US-20090176805-A1 DERIVATIVES OF ETHYLENE METHANEDISULFONATE AS CANCER CHEMOTHERAPEUTIC AGENTS CRONYN MARSHALL W 2009-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176805-A1 DERIVATIVES OF ETHYLENE METHANEDISULFONATE AS CANCER CHEMOTHERAPEUTIC AGENTS MGMT, ETV6, EI24 SRC 1622/4885ALDH1A1 2643/4885CYP2C19 996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.